Interchangeability and Pharmacy-Level Substitution
Array
Activity Info
Upon completion of the activity, participants should be able to:
1. Summarize key aspects of current and proposed regulations regarding interchangeability and pharmacist-level substitution with biosimilars
2. Access information on approved biosimilars to determine if pharmacy-level substitution will be applicable